Conclusions: Our study suggests that globally, DC predilect significatily in dorsal than in palmar surfaces of hand joints. These results should be verified on a larger population. A total 78 popliteus groove were examined by US. US findings indicative of MSU crystal deposition were detected in at least one knee in 13 out of 17 gout patients (76.5%) and in 7 out of 22 controls (31.8%). Table 1 shows the prevalence of the US abnormalities indicative of MSU crystal deposition in the two groups. Six out of the 10 US abnormalities (60%) found in controls were detected in CPPD patients. Background: In some cases differential diagnosis between yearly gouty arthritis and other types of arthritis is very difficult. In 2015 the sonographic detection of urate crystal deposits in hyaline cartilage as a new criterion was included in set of classification criteria of gout [1] . But diagnostic value of that ultrasound marker in first month of disease is underinvestigated. Objectives: To investigate sensitivity and specificity of sonographic detection of gouty hyperechoic deposits in hyaline cartilage in patients with gout in comparison with other signs of gout in debut of arthritis. Methods: The 104 patients with yearly arthritis (duration of symptoms less than 6 month) was examined by clinical, laboratory, X-Ray and ultrasonography. After investigation the following diagnoses were made: Gout in 32 patients, Osteoarthritis in 28 patients, Rheumatoid arthritis in 28 patients, Psoriatic arthritis in 16 patients. Ultrasound investigation of affected joints was performed in all subjects by linear probe 18 MHz. Urate crystal deposits were seen on the surface of the hyaline cartilage as a hyperechoic thin line or dots on the cartilage, wich sometimes imitate double contour of bones [2, 3] . Sensitivity and specificity of ultrasound sign were compared with subcutaneous tophi, bone cysts (X-Ray sign) and hyperuricemia. Results: The urate crystal deposits in gyalinic cartilage of at least one of affected joints were revealed in 28 of 32 (87,5%) patients with Gout, in 3 of 28 (10,7%) patients with Osteoarthritis and 1of 16 (6,3%) patients with Psoriatic arthritis. Comparative data of sensitivity and specificity of crystal deposits, bone cysts, subcutaneous tophi and hyperuricemia are represented in table below. Background: Increased levels of serum urate (sUA) have been reported in association with hypertension, chronic kidney disease and obesity. All these conditions are over-represented in US African Americans, who also have greater environmental risk factors for hyperuricemia development including elevated fructose intake. Our group has previously reported that young African Americans have lower sUA concentrations than Caucasians after adjustment for clinical and demographic factors. Objectives: To determine whether there is a differential association between sUA and race in young adults. Methods: We examined baseline data on consecutively enrolled individuals (age 18 -40 years) in an interventional study aimed at lower blood pressure (BP) through the administration of urate-lowering therapy. African Americans were over-represented in the sample by study-design. Inclusion criteria included a sUA of ≥5.0 mg/dL for men or ≥4.0 mg/dL for women. After means comparisons between races, we performed multivariable adjustments for age, gender, BP, and body mass index (BMI) a multiple linear regression model. Data reported are mean ±standard deviation.
Results: 86 participants recruited from Birmingham, AL were included in the analysis. Participants had a mean age of 28.5±6.9 years, 36% were female, 41% were African Americans (AAs), and the mean BMI was 29.2±6.8 kg/m 2 . The mean sUA was 5.9±1.2 mg/dL (n=77, range: 3.9 to 8.5 mg/dL). We found a significantly lower sUA for African Americans compared to persons of other races (5.4±1.2 mg/dL vs 6.2±1.1 mg/dL, p=0.005). After multivariable analysis the difference in sUA between AAs and other races was attenuated to non-significance (p=0.33) due to the effects of BMI and gender. As expected, the association between sUA and gender was significant (Table) . 
Conclusions:
In this cross-sectional analysis of young adults, AAs had lower sUA concentrations than other races. However, this difference is explained by the effect of gender differences in sUA and BMI. A potential limitation is that participants were enrolled after they met a sUA threshold so not all the ranges of sUA in a normal population are represented in this analysis. Larger studies will be needed to fully address this question. 
